Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Feb. 01, 2014	Feb. 02, 2013
Cash flows from operating activities:
Net loss	$ (12,465)	$ (56,013)
Adjustments to reconcile net loss to net cash used in operating activities:
Asset impairment	491	8,106
Loss on disposal of property and equipment	470	321
Depreciation and amortization	11,973	14,251
Amortization of deferred financing costs	916	899
Provision for losses on accounts receivable	577	203
Share-based compensation	556	4,547
Changes in operating assets and liabilities, net of effects of acquisition:
Accounts receivable	(14,548)	6,319
Inventories	(10,921)	5,934
Prepaid expenses and other assets	11,848	(12,017)
Accounts payable	5,714	(1,230)
Accounts payable-affiliates	564	2,035
Accrued expenses and other liabilities, and other long-term liabilities	3,354	19,277
Net cash used in operating activities	(1,471)	(7,368)
Cash flows from investing activities:
Additions to property and equipment	(5,500)	(7,088)
Payment to acquire Parlux, net of Parlux cash on hand of $17,114	0	(44,949)
Net cash used in investing activities	(5,500)	(52,037)
Cash flows from financing activities:
Net borrowings under bank line of credit	6,831	31,014
Borrowings under affiliated notes payable to fund Parlux acquisition	0	30,000
Principal payments under capital lease obligations	(835)	(1,072)
Proceeds from exercise of stock options and warrants	81	228
Net cash provided by financing activities	6,077	60,170
Net (decrease) increase in cash and cash equivalents	(894)	765
Cash and cash equivalents at beginning of year	2,447	1,682
Cash and cash equivalents at end of year	1,553	2,447
Cash paid during the period for:
Interest	3,331	3,183
Income taxes	29	327
Income taxes	29	327
Noncash investing and financing activities:
Fair value of equity consideration given to acquire Parlux	$ 0	$ 89,563